Le Lézard
Classified in: Health, Business
Subjects: LIC, SCZ

Amulet-Backed US Digestive Health Partners with West Chester GI Associates


EXTON, Penn., Nov. 17, 2020 /PRNewswire/ -- US Digestive Health, a management services organization created to expand access to high-quality, low-cost gastroenterology care, announced today that it has partnered with West Chester GI Associates (WCGI), a gastroenterology practice in West Chester, PA.

Including its new partnership with WCGI, US Digestive Health oversees a network of gastroenterology providers and services with 24 locations, 9 ambulatory surgery centers, 85 physicians, 41 advanced practice providers, and more than 500 total employees.

With offices throughout Central and Southeastern Pennsylvania, including the Greater Philadelphia region, US Digestive Health works hand-in-hand with independent gastroenterology partner practices to meet the challenges of a fast-changing healthcare landscape. By providing innovative business management and technology solutions that ease administrative burdens and support their financial success, US Digestive Health allows physicians to stay focused exclusively on delivering great patient care.

"We are very pleased to add WCGI to our expanding family of gastroenterology providers and to grow our presence in our core geography of Pennsylvania," said Jerry Tillinger, CEO of US Digestive Health. "As we grow, our goal stays the same ? to create true partnerships with our member practices through transparency, clear and regular communication, and the sharing of our resources to support their success."

"My colleagues and I are excited to partner with a well-established and respected organization like US Digestive Health," said David Neiblum, M.D.  "Gaining access to USDH's operational infrastructure will help us manage administrative burdens that can interfere with our ability to focus on patient care in the West Chester area."  

Ramsey Frank, Partner and Co-Founder of Amulet commented, "US Digestive Health has set a very high bar for the quality of our affiliated medical groups and WCGI fits right in.  WCGI has a very good reputation in the community and is aligned with our vision of maintaining high levels of quality and compliance."

Frank added, "As we look to expand US Digestive Health's footprint across the broader US, we believe we can offer potential future partner practices best-in-class business administration services, clinical excellence, and operational support."

US Digestive Health was formed in 2019 by Amulet Capital Partners, LP ("Amulet"), a healthcare private equity investment firm based in Greenwich, Connecticut, in partnership with member practice partner physicians.

For more information, visit https://usdigestivehealth.com/

About US Digestive Health

As the leading gastroenterology practice on the East Coast, US Digestive Health is at the forefront of the rapidly advancing science of digestive health, bringing new insight into the care, treatment and prevention of digestive health disorders. For more information, visit https://usdigestivehealth.com.

Media contact for US Digestive Health

Liz Weir
LevLane Advertising
610-401-4825
[email protected]

About Amulet Capital Partners, LP

Amulet Capital Partners, LP is a middle-market private equity investment firm based in Greenwich, CT, focused exclusively on the healthcare sector. Amulet seeks to achieve long-term capital appreciation through privately negotiated investments in companies. Amulet Capital Partners focuses on those segments it believes have the most attractive long-term fundamentals with a target investment size generally between $25 million to $150 million. For additional information, please visit www.amuletcapital.com.

Media Contact for Amulet Capital Partners, LP

Melissa Sheer
Kent Place Communications, LLC
917-690-2199
[email protected]

SOURCE US Digestive Health


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: